SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-049068
Filing Date
2024-04-26
Accepted
2024-04-26 16:01:04
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A eypt_defa14a_04-26-2024.htm DEFA14A 16568
2 GRAPHIC img145914436_0.jpg GRAPHIC 159247
3 GRAPHIC img145914436_1.jpg GRAPHIC 141863
  Complete submission text file 0000950170-24-049068.txt   432808
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-51122 | Film No.: 24883372
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)